is this a safe buy?

Teladoc Stock Tumbles After Company Misses Sales Estimates and Offers Soft Guidance

Teladoc Health Inc.’s stock tumbled 6.8% in after-hours trading Tuesday, after the virtual care company posted a narrower-than-expected loss for the third quarter but revenue that fell short of estimates. Purchase, N.Y.-based Teladoc posted a net loss of $57.1 million, or 35 cents a share, for the quarter, narrower than the loss of $73.5 million, or 45 cents a share, posted in the year-earlier period. Revenue rose 8% to $660.2 million from $611.4 million a year ago. The FactSet consensus was for
Teladoc Stock Tumbles After Company Misses Sales Estimates and Offers Soft Guidance

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Top
  • Latest
empty
No comments yet